Helen Wong

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Chad J. Creighton, Xiaoxian Li, Melissa D. Landis et al. · Proceedings of the National Academy of Sciences · 2009 · 1.4K citations · Full text

Medicine, Cancer Biology, Oncology +16

A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

Xiaomei Zhang, Sofie Claerhout, Aleix Prat et al. · Cancer Research · 2013 · 485 citations · Full text

Medicine, Cancer Biology, Oncology +9

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy

J R Dunn, Atik Baborie, F. Alam et al. · British Journal of Cancer · 2009 · 328 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors

Anne F. Schott, Melissa D. Landis, Gabriela Dontu et al. · Clinical Cancer Research · 2013 · 264 citations · Full text

Medicine, Oncology, Pharmacology +14

Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers

Bhuvanesh Dave, Ilenia Migliaccio, Maya Gutierrez et al. · Journal of Clinical Oncology · 2010 · 256 citations

Medicine, Oncology, Pharmacology +17